Kolexia
Ramdani Mohamed Gastro-entérologie
Ramdani Mohamed
Gastro-entérologie
Centre Hospitalier de Beziers
Béziers, France
47 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs colorectales Tumeurs de la tête et du cou Malnutrition Tumeurs de l'oesophage Carcinome hépatocellulaire Neuropathies périphériques Métastase tumorale Vipome Diverticule de Zenker

Collaborateurs

Voir plus
Hyrailles-Blanc Valerie
Hyrailles-Blanc Valerie
Polycl Champeau Beziers, Béziers, France
Bejaoui Mohamed
Bejaoui Mohamed
Centre Hospitalier de Beziers, Béziers, France
Altwegg Romain
Altwegg Romain
Hôpital Saint-Éloi, Montpellier, France
Assenat Eric
Assenat Eric
Icm Montpellier, Montpellier, France

Industries

Voir plus
Abbvie
5 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
5 collaboration(s)
Dernière en 2023
Sandoz
5 collaboration(s)
Dernière en 2023
Janssen
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
629P First results of the french prospective cohort of colorectal cancers with microsatellite instability (COLOMIN2)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
POCHI: Pembrolizumab in Combination With Xelox Bevacizumab in Patients With Microsatellite Stable Mestatic Colorectal Cancer and a High Immune Infiltrate : a Proof of Concept Study
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
Management of the Zenker diverticulum: multicenter retrospective comparative study of open surgery and rigid endoscopy versus flexible endoscopy.
Surgical endoscopy   28 juin 2023
Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients' Profiles With Oxaliplatin-Induced Peripheral Neuropathy.
Frontiers in pharmacology   04 novembre 2021
Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study.
Journal of clinical medicine   27 juillet 2020
Sorafenib alone vs. sorafenib plus GEMOX as 1 -line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial.
British journal of cancer   04 avril 2019
Polyarthrite aiguë rapidement destructrice avec panniculite : le syndrome PPP
77ème congrès français de médecine interne, Lyon, du 27 au 29 juin 2018   01 juin 2018
Multicenter randomized phase II trial (BEVATOMOX) assessing the raltitrexed, oxaliplatin and bevacizumab combination versus FOLFOX6 bevacizumab as 2nd line treatment in metastatic colorectal cancer (mCRC)
Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8-12 September 2017, Madrid, Spain   01 septembre 2017
Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients.
European journal of cancer (Oxford, England : 1990)   05 novembre 2016
A phase III study evaluating oral glutamine and transforming growth factor-beta 2 on chemotherapy-induced toxicity in patients with digestive neoplasm.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   15 décembre 2015